+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

A New History of Vaccines for Infectious Diseases. Immunization - Chance and Necessity

  • Book

  • January 2022
  • Elsevier Science and Technology
  • ID: 5315140

A New History of Vaccines for Infectious Diseases: Immunization - Chance and Necessity covers the developments of vaccines and how they have obliterated many fatal diseases and infections over time. The book treads a neutral path but does not avoid discussion. As uncertainty in the outcome of vaccination can only be determined by experiment, the path to vaccine development has been scientifically complex because the immune system and the manner in which humans respond to infection is variable and complex.� Finally, the book describes the risks and benefits of vaccines in a visibly objective manner.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Infectious disease protection:�A historical documentary 2. The scourge of smallpox and the genius of an 18th century country doctor 3. Smallpox vaccination in the 19th century: Obstinacy versus pragmatism 4. The biological origins of infection unveiled 5. Cholera, typhoid, paratyphoid, and plague:�A cautious start to a vaccine revolution 6. Diphtheria and tetanus: The discovery of passive immunization 7. The tuberculosis roller coaster: Vaccines and antibiotics 8. The discovery of viruses provides epic challenges for vaccinology 9. Yellow fever, Dengue and Zika: Tropical viral diseases and vaccine development 10. Influenza virus:�A scientific and evolutionary chameleon 11. The Polio virus: Its conquest amid inflamed debate and controversy 12. Measles, Mumps and Rubella: Vaccination, mortality, and uncertainty 13. Ebola and Marburg viruses: Modern solutions to life-threatening infections 14. Corona viruses: Immunological challenges of the 'new' infections 15. Vaccines are not always perfect: Adverse effects and their clinical impact 16. Vaccination and freedom of choice: The individual and the population 17. Scientific Glossary

Authors

Anthony R. Rees Founder of Rees Consulting AB, Stockholm, Sweden,, Emeritus Professor & Author. Anthony Robert Rees, educated at the University of Oxford (MSc, MA, DPhil), has had a distinguished academic and research career spanning over 30 years in receptor biology and molecular immunology. He served as a Lecturer in Molecular Biophysics at Oxford (1980-90) before becoming Professor of Biochemistry and Head of the School of Biology & Biochemistry at the University of Bath (1990-97). He was honored with an Emeritus Professorship in 2003 and a Doctor of Science Honoris Causa in 2009 by the University of Bath. Rees co-founded the Oxford University spin-out, Oxford Molecular plc, in 1989, which floated on the LSE in 1994. He held senior executive roles in French and Swedish biotech companies and was a founding board member of the Austrian antibody biotech company F-star. An expert in antibody repertoire theory, he is a consultant in immunology and a member of the American Association for the History of Medicine.